Article PDF
Avoid common mistakes on your manuscript.
References
Singh UK, Sinha RK, Sharma VK. Fulminant hepatitis in Kala-azar. Indian J Pediatr 1995; 62: 571–574.
di Martino L, Vajro P, Nocerino A, Scotti S, Napolitano G, Vegnente A. Fulminant hepatitis in an Italian infant with visceral leishmaniasis. Trans R Soc Trop Med Hyg 1992; 86: 34.
El Hag IA, Hashim FA, el Toum IA, Homeida M, el Kalifa M, el Hassan AM. Liver morphology and function in visceral leishmaniasis (Kala-azar). J Clin Pathol 1994; 47: 547–551.
Hepburn NC, Siddique I, Howie AF, Beckett GJ, Hayes PC. Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1994; 88: 453–455.
Carvalho EM, Teixeira R, Johnson WD. Cell-mediated immunity in American visceral leishmaniasis: reversible immune suppression during acute infection. Infect Immun 1981; 33: 498–502.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baranwal, A.K., Ravi, R.N.M. & Singh, R. Post-treatment fulminant hepatic failure in an infant with Visceral leishmaniasis: Immune injury or stibogluconate toxicity?. Indian J Pediatr 77, 107–108 (2010). https://doi.org/10.1007/s12098-009-0265-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-009-0265-0